Search by Drug Name or NDC

    NDC 00069-0297-10 TicoVac 1.2 ug/.25mL Details

    TicoVac 1.2 ug/.25mL

    TicoVac is a INTRAMUSCULAR INJECTION in the VACCINE category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED).

    Product Information

    NDC 00069-0297
    Product ID 0069-0297_c646a966-5d4b-4921-8e37-74e6de0b95be
    Associated GPIs 1710008610E610
    GCN Sequence Number 061305
    GCN Sequence Number Description tick-borne encephalitis vaccin SYRINGE 1.2/0.25ML INTRAMUSC
    HIC3 W7J
    HIC3 Description NEUROTOXIC VIRUS VACCINES
    GCN 97099
    HICL Sequence Number 016557
    HICL Sequence Number Description TICK-BORNE ENCEPHALITIS VACCINE
    Brand/Generic Brand
    Proprietary Name TicoVac
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tick-Borne Encephalitis Vaccine
    Product Type VACCINE
    Dosage Form INJECTION
    Route INTRAMUSCULAR
    Active Ingredient Strength 1.2
    Active Ingredient Units ug/.25mL
    Substance Name TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)
    Labeler Name Pfizer Laboratories Div Pfizer Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125740
    Listing Certified Through 2024-12-31

    Package

    NDC 00069-0297-10 (00069029710)

    NDC Package Code 0069-0297-10
    Billing NDC 00069029710
    Package 10 SYRINGE in 1 CARTON (0069-0297-10) / .25 mL in 1 SYRINGE (0069-0297-01)
    Marketing Start Date 2022-06-27
    NDC Exclude Flag N
    Pricing Information N/A